Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel vs. Risperidone in Schizophrenia
NCT00034905Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2001
- Primary completion
- Sep 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of quetiapine in schizophrenia (2 arms), sponsored by AstraZeneca. Primary endpoint: Efficacy at 8 weeks. Started Jul 2001; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00034905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034905.